Blog Archive

Powered by Blogger.
Flag Counter
Sunday, October 28, 2012

Exuviance Vespera Bionic Serum Discount Exuviance Vespera Bionic SerumSaleExuviance Vespera Bionic Serum

Exuviance Vespera Bionic Serum

Exuviance Vespera Bionic Serum


Exuviance Vespera Bionic SerumOverviews.

This antioxidant, anti aging skin serum delivers real results Users experienced a 212% improvement in skin clarity after 6 weeks with this intensive treatment. With regular use, it visibly improves fine lines and wrinkles and skin texture, and is clinically proven to result in a 212% improvement in clarity after just 6 weeks of use. Vespera Bionic Serum is wonderful on its own but can also be used as a booster under other treatments or moisturizers, or for complementary therapy following glycolic acid peels, microdermabrasion, and non-ablative laser and light procedures. Formulated with marine botanicals, this serum is suitable for all skin types, even the most sensitive skin. Formulated with (AHA) Mandelic Acid, and (PHAs) Lactobionic Acid and Gluconolactone. Multi-Antioxidant protection from Pro-Vitamins A, C and E. A marine botanical helps to smooth stressed skin.

Exuviance Vespera Bionic Serum Features.

  • Can also be used as a booster under other treatments or moisturizers, or for complementary therapy following glycolic acid peels, microdermabrasion, and non-ablative laser and light procedures
  • Clinical studies indicate that after 6 weeks of use, 89% of users claimed a significant improvement in skin texture and smoothness
  • Clinical studies indicate that after 6 weeks of use, 212% improvement in skin clarity
  • Help smooth lines and wrinkles on aging skin while protecting from oxidative damage with this concentrated treatment blended with Alpha Hydroxy and Polyhydroxy acids, Pro-Vitamins A, C, and E, and powerful antioxidants
  • This antioxidant, anti aging skin serum delivers real results Users experienced a 212% improvement in skin clarity after 6 weeks with this intensive treatment

  • Date post : 2012-10-28

    0 comments: